Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.

Clinical trial NCT04276597 · WITHDRAWN

Trial details

NCT number: NCT04276597
Sponsor: Excel Diagnostics and Nuclear Oncology Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Neuroendocrine Neoplasm Pheochromocytoma Paraganglioma Thymus Carcinoid Unknown Primary Tumors Neuroendocrine Tumors Neuroendocrine Skin Carcinoma Neuroendocrine Breast Tumor Neuroendocrine Carcinoma Metastatic Neuroendocrine Neoplasm of Ovary

Start date: 2020-03-04
Primary completion: 2021-07-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.